New angiogenesis inhibitors, WF-16775 A1 and A2.
D000482:Allantois / Q000187:drug effects; D043925:Angiogenesis Inducing Agents / Q000037:antagonists & inhibitors*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology*; D002642:Chick Embryo; D004730:Endothelium, Vascular / Q000187:drug effects; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D003904:Mitosporic Fungi / Q000737:chemistry; D009389:Neovascularization, Pathologic / Q000517:prevention & control; D011725:Pyridines / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology*; D014407:Tumor Cells, Cultured; D014471:Umbilical Veins
D043925:Angiogenesis Inducing Agents; D000900:Anti-Bacterial Agents; D011725:Pyridines; C079475:WF 16775 A2; C079474:WF 16775 A1